Showing pharmacokinetics for Daidzein metabolite after consumption of Daidzein 7-O-glucoside in humans Metabolism
Rufer C.E., Bub A., Moseneder J., Winterhalter P., Sturtz M., Kulling S.E. (2008) Pharmacokinetics of the soybean isoflavone daidzein in its aglycone and glucoside form: a randomized, double-blind, crossover study. Am J Clin Nutr 87:1314-23 PubMed (18469255)
Plasma and Urine analysed after enzymatic deconjugation
Show related sources from the same publication
Plasma Concentration (µmol/L) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Number | Dose | Multiple Dose Duration | Time (hours) |
Polyphenol Source Name as described in publication |
|||||
0 | 1 | 3 | 6 | 12 | 24 | ||||
1 | 1 capsule | Single Dose | 0 | 0 | 1.1 | 1.8 | 2.5 | 1.8 |
daidzein-7-O-glucoside capsule
|
Cumulative Excretion in Urine (µmol) | |||||||
---|---|---|---|---|---|---|---|
Number | Dose | Multiple Dose Duration | Time (hours) |
Polyphenol Source Name as described in publication |
|||
0 | 6 | 12 | 24 | ||||
1 | 1 capsule | Single Dose | 0 | 20 | 70 | 107 |
daidzein-7-O-glucoside capsule
|